← All Sponsors
SPONSOR

Daniel Keizman

Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Renal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung CancerHepatocellular CarcinomaTransitional Cell Carcinoma
NCT07485114
Recruiting

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Renal Cell Carcinoma (Kidney Cancer)
Israel View Trial →